13FPulse
中
AQ

AQST AQUESTIVE THERAPEUTICS INC

2026Q2 · CUSIP 03843E104 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
182
Institutions that reported holding it to the SEC
Net increase in holders
+7
Last quarter 175 → now 182
How unusual is that
Above average
Stronger buying than 62% of US stocks
What the filings say, in one paragraph

182 funds held AQST at the end of 2026Q2, up 7 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $54M(YoY +22.6%). AQST has had 4 buying rushes in its history, and the price moved -12.1% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2018Q4: holders=36 2019Q1: holders=49 2019Q2: holders=40 2019Q3: holders=35 2019Q4: holders=57 2020Q1: holders=42 2020Q2: holders=57 2020Q3: holders=59 2020Q4: holders=65 2021Q1: holders=63 2021Q2: holders=60 2021Q3: holders=46 2021Q4: holders=51 2022Q1: holders=49 2022Q2: holders=45 2022Q3: holders=46 2022Q4: holders=37 2023Q1: holders=35 2023Q2: holders=54 2023Q3: holders=48 2023Q4: holders=56 2024Q1: holders=96 2024Q2: holders=97 2024Q3: holders=115 2024Q4: holders=113 2025Q1: holders=120 2025Q2: holders=115 2025Q3: holders=151 2025Q4: holders=177 2026Q1: holders=175 2026Q2: holders=182 -40 -20 +0 +20 +40 31112192 18Q419Q320Q221Q121Q422Q323Q224Q124Q425Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 4 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2025Q3 Top 10% -32.0% -28.4%
2024Q3 Top 20% -35.1% -50.6%
2024Q1 Top 10% +37.0% +42.8%
2023Q2 Top 20% — —

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
93
Change in large funds
+11
Total value they hold
$299M
Funds buying for the first time
31
Funds that sold out entirely
24
Price change that quarter
+21.4%
Funds holding puts (bearish)
3
Funds holding calls (bullish)
5

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.65
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+22.6%
Net margin
-144.6%
ROE
—
Debt ratio
142.8%
FCF (TTM)
-$46M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.37 2021-12-31: EPS -0.74 2022-03-31: EPS -0.32 2022-06-30: EPS -0.36 2022-09-30: EPS -0.23 2022-12-31: EPS -0.21 2023-03-31: EPS 0.11 2023-06-30: EPS -0.10 2023-09-30: EPS -0.03 2023-12-31: EPS -0.11 2024-03-31: EPS -0.17 2024-06-30: EPS -0.03 2024-09-30: EPS -0.13 2024-12-31: EPS -0.18 2025-03-31: EPS -0.24 2025-06-30: EPS -0.14 2025-09-30: EPS -0.14 2025-12-31: EPS -0.26 2026-03-31: EPS -0.07 2026-06-30: EPS -0.18 0M 14M 27M $M -0.81 -0.35 0.12 201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-24M-4M15M 2017201820192020202120222023202420252026
Latest quarter $-15M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.